$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
吉妥单抗可延长急性髓性白血病的生存期
2025-10-19 11:44:20
Check Details
阿卡替尼治疗慢性淋巴细胞白血病的安全性和有效性
2025-10-19 11:44:20
Check Details
用吉妥单抗治疗急性髓性白血病的费用
2025-10-19 11:44:20
Check Details
二代BTK抑制剂阿卡替尼治疗效果怎么样?
2025-10-19 11:44:20
Check Details
白血病治疗药吉妥单抗安全性及有效性
2025-10-19 11:44:20
Check Details
急性髓性白血病新药吉妥单抗去哪能买到?
2025-10-19 11:44:20
Check Details
慢性淋巴细胞白血病治疗新选择:阿卡替尼
2025-10-19 11:44:20
Check Details
吉妥单抗能治疗老年急性髓系白血病(AML)吗?
2025-10-19 11:44:20
Check Details
白血病新药吉妥单抗在国内医院能够买到吗?
2025-10-19 11:44:20
Check Details
吉妥单抗获FDA批准用于CD33阳性急性髓性白血病
2025-10-19 11:44:20
Check Details
阿卡替尼是一款可用于治疗慢性淋巴细胞白血病的BTK抑制剂
2025-10-19 11:44:20
Check Details
第二代BTK抑制剂阿卡替尼的禁忌和用药注意事项
2025-10-19 11:44:20
Check Details
1
2
...
597
598
599
600
601
602
603
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
2
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
3
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
4
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
5
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
6
A Key Therapeutic Breakthrough Against T315I-Mutant CML
7
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
8
Tafasitamab and Lenalidomide Combination Therapy Guide
9
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
10
Gilteritinib Professional Medication Guide & Dosage Management
11
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
12
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia